Sichuan Hebang Biotechnology Corporation Limited

SSE:603077.SS

1.69 (CNY) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q3
Revenue 1,952.0022,822.2171,987.6032,366.7762,343.8491,696.1452,394.4682,545.6233,014.2954,392.8933,086.1362,798.693,155.5672,257.9331,654.9191,366.7521,451.1781,419.3761,023.461,221.3071,687.2271,632.8611,427.7061,451.8411,641.2461,764.5331,151.3991,432.4381,276.9221,100.138928.1471,094.329918.526781.213668.484837.366666.8870.155488.323731.77537.454524.046392.429524.649429.636312.831335.548349.574342.696529.013516.487454.482543.855
Cost of Revenue 1,777.7562,538.1871,797.1371,911.6171,761.6371,355.4371,769.4921,751.0171,838.2182,245.271,616.811,519.7451,652.7231,338.1551,219.0231,137.9751,110.2271,168.616855.148943.4581,281.8291,242.6721,141.2141,144.91,249.8711,338.563947.5011,014.491,018.342874.667627.352831.502700.91590.078513.692634.215531.127682.841386.707556.279434.204437.819299.08409.584383.415258.422244.049263.999226.67301.738292.805196.639284.611
Gross Profit 174.246284.03190.466455.159582.212340.708624.976794.6061,176.0772,147.6241,469.3261,278.9441,502.844919.778435.896228.776340.951250.76168.313277.849405.398390.19286.491306.94391.374425.97203.899417.949258.58225.472300.795262.827217.615191.135154.791203.151135.672187.314101.615175.491103.2586.22793.348115.06546.2254.4191.49985.575116.026227.276223.683257.843259.244
Gross Profit Ratio 0.0890.1010.0960.1920.2480.2010.2610.3120.390.4890.4760.4570.4760.4070.2630.1670.2350.1770.1640.2280.240.2390.2010.2110.2380.2410.1770.2920.2030.2050.3240.240.2370.2450.2320.2430.2030.2150.2080.240.1920.1650.2380.2190.1080.1740.2730.2450.3390.430.4330.5670.477
Reseach & Development Expenses 7.7252.2618.34611.49910.53599.10843.4867.59.2827.6669.3767.7987.848.2999.22810.4649.46410.52110.4399.539.348.99210.1595.6178.0837.04250.5827.00513.14028.1460003.8090000000000012.45400000
General & Administrative Expenses 252.367-54.259106.561-175.163230.996-68.696106.161-549.166351.84687.394183.453-214.459244.305-55.80291.606-142.49765.286-39.93682.518-144.68385.463-31.23657.566-82.90161.664-39.25168.052-104.13171.43-16.98250-68.88243.948-14.21340.306-46.69927.059-8.91220.489-39.63719.954-8.25518.317-34.96216.878-5.20216.989-21.37115.18724.74916.679-35.7718.789
Selling & Marketing Expenses -118.95316.84716.37218.49713.7813.42713.85915.05916.518.91811.99614.74914.5239.44113.374-114.67456.89461.51960.18866.33771.04989.01963.168107.5396.83884.57450.4676.6959.20960.88661.95873.70259.47563.62848.38132.36455.05546.0413.35929.92326.48623.25221.61543.47410.83714.73112.51516.61110.17913.19911.90628.38917.807
SG&A 133.41473.091137.46135.863244.775-55.269120.021-534.107368.35596.312195.448-199.71258.828-46.361104.979-257.171122.1821.583142.706-78.346156.51257.782120.73424.629158.50245.323118.512-27.442130.63943.904111.9594.819103.42349.41588.687-14.33482.11437.12833.848-9.71446.4414.99739.9328.51227.7159.52829.504-4.7625.36637.94828.584-7.38136.596
Other Expenses -2.604-3.927-0.004-36.752-0.05-0.09111.127778.537-96.038159.66711.592-12.887-2.6182.808021.892-444.612-0.1-1.8651.0810.0051.8791.4983.711-2.689-0.0140.729-11.4265.459-0.1396.39410.7341.06710.967.94762.5860.4550.170.320.3210.160.230.0020.1014.22732.7910.0511.9315.0986.5998.422-0.007-0.012
Operating Expenses 143.74379.279145.806184.113127.175102.33140.256287.915279.817265.261214.70782.358169.44110.876123.4425.004135.819157.372159.741207.435175.144171.648134.462227.671175.918155.758127.123169.871139.945129.24117.779155.603108.393112.66196.31693.21187.07985.46837.54772.63251.42253.19245.85778.96531.68342.3236.17968.34131.1746.56836.89175.32544.887
Operating Income 30.502204.75144.659271.046481.053252.343477.206439.662935.431,875.9921,230.0731,201.2081,316.104785.743292.858210.165198.66182.667-5145.372190.932216.262130.097-89.248200.839246.25556.11214.91295.79487.303197.788144.58476.06863.65754.69925.76532.675116.52843.78-18.89920.537643.34733.74223.7760.043-0.96847.48410.65160.143150.678162.746154.671185.173
Operating Income Ratio 0.0160.0730.0220.1150.2050.1490.1990.1730.310.4270.3990.4290.4170.3480.1770.1540.1370.058-0.050.0370.1130.1320.091-0.0610.1220.140.0490.150.0750.0790.2130.1320.0830.0810.0820.0310.0490.1340.09-0.0260.0381.2280.0860.0450-0.0030.1420.030.1760.2850.3150.340.34
Total Other Income Expenses Net -16.322-0.443-0.00455.081-0.05-0.091-0.622-0.115-4.673-0.011-2.444-12.367-5.5082.8080.39621.892-444.612-2.7-1.8651.0810.0050.00403.711-2.689-0.0140.729-11.426-2.658-3.4836.3942.9231.06710.967.94762.5860.4550.1640.3210.3210.160.230.0020.1010-9.368-7.7865.56000-0.057-0.012
Income Before Tax 14.181201.71243.609320.221481.003252.252476.584439.547935.4041,875.9811,227.6291,188.3211,313.486788.551292.858232.057-245.95182.567-52.86546.453190.937216.266130.097-85.537198.15246.24156.839203.486101.25387.164204.182155.19777.13574.61662.64688.35133.13116.69344.101-18.57920.697643.57733.74423.8770.043-0.96847.53416.21160.143150.678162.746154.614185.161
Income Before Tax Ratio 0.0070.0710.0220.1350.2050.1490.1990.1730.310.4270.3980.4250.4160.3490.1770.17-0.1690.058-0.0520.0380.1130.1320.091-0.0590.1210.140.0490.1420.0790.0790.220.1420.0840.0960.0940.1060.050.1340.09-0.0250.0391.2280.0860.0460-0.0030.1420.0460.1760.2850.3150.340.34
Income Tax Expense 6.69240.80716.46561.50370.06930.57195.12363.676141.791280.353182.503180.579200.663119.3651.2770.050.28811.5281.033-11.07231.9935.72520.49933.21528.18442.86813.2233.25814.50810.43532.69115.51112.2839.1611.17414.8934.50518.295.8532.4681.1871.3272.6951.477-0.651-1.2936.5241.6998.38821.51623.28269.6530.316
Net Income 29.049162.47729.793264.2402.513219.971396.561379.307792.8671,591.911,042.7251,009.9421,099.09663.476250.798239.809-243.88976.349-31.32751.921167.394184.449113.09-85.35174.628223.99949.81173.3488.22884.012171.959132.39562.69769.11953.60174.59128.62498.40338.248-21.04719.51642.2531.04922.3990.6940.33141.01314.51251.755129.163139.46484.964154.845
Net Income Ratio 0.0150.0580.0150.1120.1720.130.1660.1490.2630.3620.3380.3610.3480.2940.1520.175-0.1680.054-0.0310.0430.0990.1130.079-0.0590.1060.1270.0430.1210.0690.0760.1850.1210.0680.0880.080.0890.0430.1130.078-0.0290.0361.2260.0790.0430.0020.0010.1220.0420.1510.2440.270.1870.285
EPS 0.0040.020.0030.0310.0460.0250.0450.0440.0920.180.120.120.130.0790.030.03-0.030.01-0.0040.0060.020.0160.01-0.010.020.0450.010.020.010.0090.020.0190.010.0120.0090.0110.0050.0160.005-0.0030.0030.110.0050.005000.0070.0030.0090.0280.030.0180.033
EPS Diluted 0.0040.020.0030.0310.0460.0250.0450.0440.0910.180.120.120.130.0790.030.03-0.030.01-0.0040.0060.020.0160.01-0.010.020.0450.010.020.010.0090.020.0190.010.0120.0090.0110.0050.0160.005-0.0030.0030.110.0050.005000.0070.0030.0090.0280.030.0180.033
EBITDA 37.984470.959308.302579.826750.143471.324729.215681.5551,184.6022,110.4991,464.4861,363.1581,494.318966.141469.771386.452-74.375268.566130.957210.497370.611372.889284.26182.936216.099256.06181.564270.617127.27136.67188.836200.722109.223135.01958.476188.08448.593170.60564.069680.85751.828685.30851.37870.82714.53758.17355.3256.19184.856180.708186.792197.533214.357
EBITDA Ratio 0.0190.1670.1550.2450.320.2780.3050.2680.3930.480.4750.4870.4740.4280.2840.283-0.0510.1890.1280.1720.220.2280.1990.0570.1320.1450.0710.1890.10.1240.2030.1830.1190.1730.0870.2250.0730.1960.1310.930.0961.3080.1310.1350.0340.1860.1650.1610.2480.3420.3620.4350.394